Skip to content
士泽生物医药 logo

士泽生物医药 Alternatives & Competitors

12 companies similar to 士泽生物医药 — 病人第一 ,刀锋第二 ,股东第三

Companies similar to 士泽生物医药

BlueRock Therapeutics logo — alternative to 士泽生物医药

BlueRock Therapeutics

Striving to transform the treatment of disease by harnessing the power of cell therapy

CRISPR Therapeutics logo — alternative to 士泽生物医药

CRISPR Therapeutics

Gene-based medicines for patients with serious diseases

KeifeRx logo — alternative to 士泽生物医药

KeifeRx

KeifeRx is a biopharmaceutical company finding disease-modifying treatments for neurodegen...

BIORCHESTRA Co., Ltd. logo — alternative to 士泽生物医药

BIORCHESTRA Co., Ltd.

We develop novel RNA-based therapeutics that will be able to bring about a paradigm shift...

Rival Readout

Competing with 士泽生物医药? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
Ultragenyx logo — alternative to 士泽生物医药

Ultragenyx

Going Beyond Every Day

Cullinan Therapeutics logo — alternative to 士泽生物医药

Cullinan Therapeutics

Science That Moves

Heartseed Inc. logo — alternative to 士泽生物医药

Heartseed Inc.

Clinical-stage biotech company developing iPSC-derived highly purified ventricular cardiom...

SyneuRx International (Taiwan) Corp. logo — alternative to 士泽生物医药

SyneuRx International (Taiwan) Corp.

Developing new classes of drugs for COVID-19 and multiple major central nervous system dis...

Adendra Therapeutics logo — alternative to 士泽生物医药

Adendra Therapeutics

Translating dendritic cell biology into new therapies for cancer and autoimmunity.

Jasper Therapeutics logo — alternative to 士泽生物医药

Jasper Therapeutics

Jasper is a biotechnology company focused on targeting mast cells and stem cells to treat...

Avidity Biosciences, Inc. logo — alternative to 士泽生物医药

Avidity Biosciences, Inc.

At Avidity, we are developing a new class of oligonucleotide-based therapies.

Cellcolabs logo — alternative to 士泽生物医药

Cellcolabs

Cellcolabs mission is to prevent and cure diseases by making high quality stem cells avail...

About 士泽生物医药

士泽生物医药, a promising biopharmaceutical startup founded in 2021, is dedicated to revolutionizing treatments for significant diseases lacking clinical solutions, such as Parkinson's disease. The firm employs scalable, low-cost stem cell therapies, leveraging the potential of human pluripotent stem cells capable of u...

Services

Research and Development, Clinical Trials for CNS diseases, iPSC-derived Drug Development, Technology Platform Innovation

Target Customers

Medical Researchers, Healthcare Providers, Patients with CNS Diseases, Pharmaceutical Companies

Business keywords

Stem Cell Therapy, Degenerative Diseases, IPS Cells, Regenerative Medicine, Cellular Reprogramming, Neurodegenerative Disorders, Gene Editing, Parkinson's Disease, Cell Replacement Therapy, Biotech R&D, Cell Drug Safety, Therapeutic Innovation, Biopharmaceuticals, Translational Research, Cellular Differentiation

Business Model

B2B, B2C, B2D

Revenue Model

Licensing, Service Fee, Performance Based

Frequently Asked Questions

Companies similar to 士泽生物医药 include BlueRock Therapeutics, CRISPR Therapeutics, KeifeRx, BIORCHESTRA Co., Ltd., Ultragenyx. They work in Biopharma and Biotechnology and share 士泽生物医药's focus on regenerative medicine, biopharmaceuticals and gene editing.
Bounce Watch lists 12 companies that share 士泽生物医药's industries and are closest to it in business tags, services, target customers, business model and size.
士泽生物医药, a promising biopharmaceutical startup founded in 2021, is dedicated to revolutionizing treatments for significant diseases lacking clinical solutions, such as Parkinson's disease. The firm employs scalable, low-cost stem cell therapies, leveraging the potential of human pluripotent stem cells capable of u...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around 士泽生物医药: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at 士泽生物医药 on 22 Mar 2026. The 12 companies listed here were last checked between 11 Mar 2026 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout